News for 'Pharma'

Indian Equities Bounce Back: Sensex Jumps 639 Pts, Nifty Up 194 Pts

Indian Equities Bounce Back: Sensex Jumps 639 Pts, Nifty Up 194 Pts

Rediff.com27 Apr 2026

Indian benchmark stock indices Sensex and Nifty rebounded nearly 1 per cent, snapping a three-day decline, driven by rallies in Reliance Industries and Sun Pharma, alongside positive global market trends and easing geopolitical tensions.

Stock markets today: Sensex, Nifty turn flat after falling in early trade

Stock markets today: Sensex, Nifty turn flat after falling in early trade

Rediff.com26 May 2026

The BSE benchmark traded 44.43 points up at 76,521.93, and the Nifty quoted 17.20 points higher at 24,048.85. Track Stock markets on May 26.

Drug Trafficker Dola's Chemist Links Under Investigation

Drug Trafficker Dola's Chemist Links Under Investigation

Rediff.com3 May 2026

Investigators are probing the network of Mohammad Salim Dola, an alleged international drug trafficker, and have uncovered links with chemists and pharma dealers who allegedly aided his illicit trans-national racket.

Indian Equities Rally: Banks Lead as Global Trends Boost Market Sentiment

Indian Equities Rally: Banks Lead as Global Trends Boost Market Sentiment

Rediff.com22 May 2026

Indian stock market benchmark indices closed higher, driven by strong performance in blue-chip bank shares and a positive trend in global markets, with hopes of progress in US-Iran peace negotiations also contributing to optimism.

High Crude Prices, Global Cues Drag Indian Stock Markets Lower

High Crude Prices, Global Cues Drag Indian Stock Markets Lower

Rediff.com30 Apr 2026

Indian benchmark stock indices, Sensex and Nifty, closed nearly 1 per cent lower due to surging crude oil prices, weak global market trends, and significant foreign fund outflows, with geopolitical tensions and inflation concerns further dampening investor sentiment.

Stock Markets Today: Sensex, Nifty Surge as Global Markets Rally, Oil Price Eases

Stock Markets Today: Sensex, Nifty Surge as Global Markets Rally, Oil Price Eases

Rediff.com21 May 2026

Indian benchmark equity indices, Sensex and Nifty, opened higher, tracking positive global trends and easing crude oil prices, fueled by hopes of a swift resolution to the West Asia conflict. Track Nifty 50 and BSE Sensex performance and key global triggers.

Stock Markets Surge as Crude Oil Dips Below $100 Amid US-Iran Deal Hopes

Stock Markets Surge as Crude Oil Dips Below $100 Amid US-Iran Deal Hopes

Rediff.com25 May 2026

Indian benchmark equity indices Sensex and Nifty surged in early trade, driven by a sharp correction in crude oil prices below USD 100 per barrel and a rally in global markets, fuelled by improving sentiment surrounding US-Iran negotiations.

Sensex, Nifty Surge Over 1% as Crude Oil Drops Below $100/Barrel on US-Iran Deal Hopes

Sensex, Nifty Surge Over 1% as Crude Oil Drops Below $100/Barrel on US-Iran Deal Hopes

Rediff.com25 May 2026

Indian benchmark equity indices, Sensex and Nifty, surged over 1 per cent, driven by a significant correction in crude oil prices and a global market rally, fueled by improving sentiment surrounding potential US-Iran negotiations.

Seniors to Drive 25% of India's Pharma

Seniors to Drive 25% of India's Pharma

Rediff.com21 Nov 2025

'Once the 60-plus population hits 20 to 30 per cent of the country, the demand for elderly-care treatments will surge -- cardiac, metabolic, neurological, and musculoskeletal medicines are going to dominate the market for the next several decades.'

Cough Syrup Deaths: This Is Sresan Pharma Owner

Cough Syrup Deaths: This Is Sresan Pharma Owner

Rediff.com11 Oct 2025

In a major development in the toxic syrup tragedy that killed 23 children in Madhya Pradesh, S Ranganathan, director of the Tamil Nadu-based Sresan Pharmaceuticals, has been arrested and remanded to 10 days' police custody.

Smallcap Schemes Lead Mutual Fund Rally

Smallcap Schemes Lead Mutual Fund Rally

Rediff.com1 Jun 2026

Most actively-managed equity mutual fund schemes outperformed their benchmarks despite volatility across domestic equity markets during the past year.

Pharma stocks slide as US headwinds hurt

Pharma stocks slide as US headwinds hurt

Rediff.com16 Sep 2025

Concerns over weakening demand for Indian pharmaceutical (pharma) drugs in the US - their largest export market - have weighed heavily on investor sentiment this year. While the Nifty 50 has gained 6.02 per cent year - to - date (as on September 15), the Nifty Pharma index has declined 5.18 per cent, National Stock Exchange data shows.

Indian Equities Snap Losing Streak, End Marginally Higher

Indian Equities Snap Losing Streak, End Marginally Higher

Rediff.com13 May 2026

Indian benchmark equity indices, Sensex and Nifty, closed marginally higher, breaking a four-day losing streak, despite elevated crude oil prices and ongoing geopolitical uncertainties. The market saw a temporary pause in panic selling, though cautious sentiment persists.

Mumbai businesswoman stripped, filmed at gunpoint in pharma firm office

Mumbai businesswoman stripped, filmed at gunpoint in pharma firm office

Rediff.com1 Dec 2025

As per the FIR, the woman was called to the company's office, where she was allegedly assaulted and stripped.

Diagnostics sector poised for robust Q4 growth, outperforming healthcare peers

Diagnostics sector poised for robust Q4 growth, outperforming healthcare peers

Rediff.com20 Apr 2026

The diagnostics sector is projected to significantly outperform other healthcare segments like pharmaceuticals and hospitals in Q4FY26, driven by increasing volumes, stable realisations, and a domestic focus that insulates it from geopolitical risks.

Stock Markets Edge Higher, IT Sector Shines Amid Volatility

Stock Markets Edge Higher, IT Sector Shines Amid Volatility

Rediff.com18 May 2026

Indian benchmark indices, Sensex and Nifty, closed marginally higher after a volatile trading session, driven by value buying in IT and select blue-chip counters, despite global crude price hikes and a weak rupee.

Agilisium invests in AI to transform pharma, biotech and medical tech companies

Agilisium invests in AI to transform pharma, biotech and medical tech companies

Rediff.com18 Mar 2026

Agilisium has invested Rs 50 crore to help pharmaceutical, biotech, and medical technology companies operationalise artificial intelligence, introducing a new professional standard called Forward Deployment Experts (FDX).

Massive Fake Degree Racket Uncovered In Kanpur

Massive Fake Degree Racket Uncovered In Kanpur

Rediff.com18 May 2026

Kanpur police have exposed a large-scale fake degree racket, arresting two individuals allegedly involved in supplying forged educational documents across multiple states. The operation uncovered fake marksheets, migration certificates, and degrees from various universities, raising concerns about the integrity of academic credentials and potential implications for employment and admissions.

Tax changes sweeten the deal, making share buybacks attractive for Indian companies

Tax changes sweeten the deal, making share buybacks attractive for Indian companies

Rediff.com5 May 2026

Indian companies are increasingly turning to share buybacks as a preferred payout strategy, driven by recent tax framework changes that make them more tax-efficient for non-promoter shareholders and a fall in stock prices.

India's West Asia Trade Contracts for Second Month Amid Shipping Disruptions

India's West Asia Trade Contracts for Second Month Amid Shipping Disruptions

Rediff.com15 May 2026

India's trade with West Asia saw a significant decline of over 28% in April, marking the second consecutive month of contraction. This downturn is attributed to severe shipping disruptions stemming from the ongoing conflict involving the US, Israel, and Iran, particularly impacting the crucial Strait of Hormuz waterway.

Strong therapies, JB to lift Torrent Pharma

Strong therapies, JB to lift Torrent Pharma

Rediff.com18 Nov 2025

A strong performance in the July-September quarter of 2025-26 (FY26) and expectations of growth from launches and acquisition-led synergies led to a 6.65 per cent jump in the share price of Torrent Pharmaceuticals.

Rupee's record low, crude prices pull Indian markets lower

Rupee's record low, crude prices pull Indian markets lower

Rediff.com19 May 2026

Indian stock markets concluded Tuesday's trading session lower, reversing intraday gains due to late-session selling in blue-chip stocks like HDFC Bank and Reliance Industries. The decline was primarily driven by the Indian rupee hitting a new record low against the US dollar and elevated global crude oil prices, compounded by geopolitical uncertainties.

Couple Banned from UK Companies for Breaching Disqualification Order

Couple Banned from UK Companies for Breaching Disqualification Order

Rediff.com5 Apr 2026

An Indian-origin couple in the UK has been sentenced for breaching a disqualification order, operating companies despite a ban imposed after tax fraud claims.

Indian Equities Close Lower as Geopolitical Tensions, FII Outflows Weigh

Indian Equities Close Lower as Geopolitical Tensions, FII Outflows Weigh

Rediff.com7 May 2026

Indian benchmark indices, Sensex and Nifty, ended lower in choppy trade, with the Sensex declining 114 points, as investors reacted to unabated foreign fund outflows and rising geopolitical uncertainties.

Search Launched For Missing Student In Uttar Pradesh

Search Launched For Missing Student In Uttar Pradesh

Rediff.com8 May 2026

A 24-year-old student, who is also the nephew of a BJP MLA, has gone missing from a medical college in Bareilly, Uttar Pradesh, prompting a police investigation.

Stock markets today: Sensex, Nifty50 in red amid volatile trade

Stock markets today: Sensex, Nifty50 in red amid volatile trade

Rediff.com7 May 2026

Indian benchmark indices Sensex and Nifty experienced volatile trade, declining in early deals before fluctuating, as investors reacted to unabated foreign fund outflows and rising geopolitical uncertainties, particularly in West Asia.

Stock Markets Today: Sensex, Nifty50 Rally as US-Iran Tensions Ease

Stock Markets Today: Sensex, Nifty50 Rally as US-Iran Tensions Ease

Rediff.com16 Apr 2026

Indian markets on Dalal Street rallied sharply as easing tensions in the US-Iran conflict and stable oil prices boosted sentiment. Track Nifty50 and BSE Sensex performance and key global triggers.

Stock Markets Today: Sensex, Nifty50 Down on Strait of Hormuz Tensions, Weak Rupee

Stock Markets Today: Sensex, Nifty50 Down on Strait of Hormuz Tensions, Weak Rupee

Rediff.com5 May 2026

Indian equities on Dalal Street saw volatility as global market trends and weak rupee impacted investor sentiment. Track Sensex, Nifty50 movement and key market drivers for May 5, 2026.

Stock Markets Today: Sensex, Nifty50 React to Global Cues as US-Iran peace talks fail

Stock Markets Today: Sensex, Nifty50 React to Global Cues as US-Iran peace talks fail

Rediff.com13 Apr 2026

Equity benchmark indices Sensex and Nifty tumbled in early trade on Monday, with the 30-share BSE Sensex falling 1,613.09 points and the 50-share NSE Nifty plunging 495 points, as the failure of US-Iran negotiations heightened concerns of a prolonged conflict driving crude oil prices sharply higher. Track Sensex, Nifty50 movement and key market drivers for April 13, 2026.

Stock Markets Today: Sensex, Nifty Tumble as West Asia Conflict & PM Modi's Austerity Appeal Spook Investors

Stock Markets Today: Sensex, Nifty Tumble as West Asia Conflict & PM Modi's Austerity Appeal Spook Investors

Rediff.com11 May 2026

Indian stock markets experienced a significant sell-off, with the Sensex tumbling over 1,300 points, driven by escalating crude oil prices due to US-Iran tensions and Prime Minister Narendra Modi's call for austerity measures, which amplified investor concerns about India's economic outlook.

India's M&A market resilient, poised for $200 billion annual run-rate

India's M&A market resilient, poised for $200 billion annual run-rate

Rediff.com11 May 2026

India's mergers and acquisitions (M&A) market is projected to maintain an annual run-rate of approximately $200 billion, evenly split between domestic, inbound, and outbound transactions, despite global geopolitical turbulence, according to Rajesh Singhi, global co-head, M&A Advisory, Standard Chartered Bank.

Pharma owner arrested over cough syrup that killed 20 children

Pharma owner arrested over cough syrup that killed 20 children

Rediff.com9 Oct 2025

S Ranganathan, the owner of the Tamil Nadu-based pharmaceuticals company that manufactured the Coldrif cough syrup linked to 20 children's deaths, has been arrested.

Indian pharma companies see sharp drop in adverse USFDA findings in 2025

Indian pharma companies see sharp drop in adverse USFDA findings in 2025

Rediff.com8 Jan 2026

The US Food and Drug Administration (USFDA) recorded a significant decline in serious regulatory findings at Indian drug manufacturing facilities between January and December 2025. Data reveals that 'official action indicated' (OAI) cases - the most severe classification - nearly halved over the past year.

Lukkhe Review: Familiar Drugs And Deceit Tale

Lukkhe Review: Familiar Drugs And Deceit Tale

Rediff.com8 May 2026

Lukkhe plunges into Chandigarh's dark underbelly, exploring a drug epidemic, political corruption, and a burgeoning rap scene, though its narrative often feels like a familiar crime drama, notes Deepa Gahlot.

Sensex Jumps 919 Points as Financial Stocks Lead Market Rebound

Sensex Jumps 919 Points as Financial Stocks Lead Market Rebound

Rediff.com10 Apr 2026

Indian benchmark indices Sensex and Nifty surged over 1 per cent, with the Sensex jumping 918.60 points, driven by strong buying in banking and financial counters and a positive trend in global equities, fuelled by hopes of easing West Asia tensions.

Stock Markets Today: Sensex, Nifty50 Dive as Oil Prices Surge, Foreign Funds Exit

Stock Markets Today: Sensex, Nifty50 Dive as Oil Prices Surge, Foreign Funds Exit

Rediff.com24 Apr 2026

Indian benchmark indices Sensex and Nifty experienced a significant tumble in early trade, driven by surging global oil prices, continuous outflows by Foreign Institutional Investors (FIIs), and persistent geopolitical uncertainties, particularly in West Asia.

AI is fast becoming central to how drugs will be discovered

AI is fast becoming central to how drugs will be discovered

Rediff.com25 Feb 2026

Artificial intelligence (AI) is no longer a side conversation for Indian pharma. It is fast becoming central to how drugs will be discovered, made, and supplied. Along with that shift comes a sharper focus on innovation, on the one hand, and quality and trust, on the other.

Sensex, Nifty Extend Losses as Surging Oil Prices and IT Sell-off Hit Markets

Sensex, Nifty Extend Losses as Surging Oil Prices and IT Sell-off Hit Markets

Rediff.com24 Apr 2026

Indian equity benchmark indices Sensex and Nifty tumbled over 1 per cent for the third consecutive day, driven by a sharp rally in crude oil prices, massive selling in IT stocks, and unabated foreign fund outflows amid ongoing geopolitical tensions in the Middle East.

Oil Price Surge, FII Outflows Drag Indian Stock Markets Lower

Oil Price Surge, FII Outflows Drag Indian Stock Markets Lower

Rediff.com28 Apr 2026

Indian benchmark indices Sensex and Nifty experienced declines due to a sharp rally in crude oil prices, continuous foreign fund outflows, and geopolitical uncertainties. Regulatory developments in the banking sector, particularly the implementation of the Expected Credit Loss (ECL) framework, also contributed to the selling pressure.

Obesity Drug Can't Be Advertised Anymore

Obesity Drug Can't Be Advertised Anymore

Rediff.com12 Mar 2026

'Any promotional activity carried out under the pretext of disease awareness, influencer engagement, corporate campaigns, or similar activities that create brand recall/product visibility of the prescription shall also be treated as violations.'